Subject to change.
Subject to change.
Dr. Larry Vaughan is currently Director of Scientific Affairs at BD. He previously held the position of Director of Research and Development, where he led molecular assay development. His team developed the BD Onclarity™ HPV Assay, which received U.S. PMA approval in February 2018, extended genotyping approval in 2020, and self-collection approval in 2024. This work culminated in a change in the ASCCP management guidelines to include extended genotyping and self-collection.